Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk-Based 6MP Adherence Enhancement Strategies in Children, Adolescent and Young Adults With ALL
NCT06639958Suspended
- Sponsor
- Children's Oncology Group
- Start
- Dec 2024
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Randomised, open-label trial (4 arms), sponsored by Children's Oncology Group. Primary endpoints: Participation Rate, Refusal Reasons and 2 more. Started Dec 2024; status: suspended.
Beyond the preview
Go deeper on NCT06639958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06639958.